Lee CT - Search Results

1

Development of a multiplex quantitative PCR signature to predict progression in non-muscle-invasive bladder cancer.

Wang R, Morris DS, Tomlins SA, Lonigro RJ, Tsodikov A, Mehra R, Giordano TJ, Kunju LP, Lee CT, Weizer AZ, Chinnaiyan AM. Wang R, et al. Among authors: lee ct. Cancer Res. 2009 May 1;69(9):3810-8. doi: 10.1158/0008-5472.CAN-08-4405. Epub 2009 Apr 21. Cancer Res. 2009. PMID: 19383904 Free PMC article.

2

Utility of cytokeratin 20 and Ki-67 as markers of urothelial dysplasia.

Kunju LP, Lee CT, Montie J, Shah RB. Kunju LP, et al. Among authors: lee ct. Pathol Int. 2005 May;55(5):248-54. doi: 10.1111/j.1440-1827.2005.01821.x. Pathol Int. 2005. PMID: 15871722 Free article.

3

Use of the National Cancer Data Base to develop clinical trials accrual targets that are appropriate for minority ethnicity patients: a report from the American College of Surgeons Oncology Group (ACOSOG) Special Population Committee.

Newman LA, Lee CT, Parekh LP, Stewart AK, Thomas CR Jr, Beltran RA, Lucci A, Green B, Ota D, Nelson H; American College of Surgeons Oncology Group (ACOSOG) Special Population Committee. Newman LA, et al. Among authors: lee ct. Cancer. 2006 Jan 1;106(1):188-95. doi: 10.1002/cncr.21592. Cancer. 2006. PMID: 16333856 Free article.

4

Gender and geographic influence on the racial disparity in bladder cancer mortality in the US.

Underwood W 3rd, Dunn RL, Williams C, Lee CT. Underwood W 3rd, et al. Among authors: lee ct. J Am Coll Surg. 2006 Feb;202(2):284-90. doi: 10.1016/j.jamcollsurg.2005.09.009. Epub 2005 Dec 19. J Am Coll Surg. 2006. PMID: 16427554

5

Cystectomy delay more than 3 months from initial bladder cancer diagnosis results in decreased disease specific and overall survival.

Lee CT, Madii R, Daignault S, Dunn RL, Zhang Y, Montie JE, Wood DP Jr. Lee CT, et al. J Urol. 2006 Apr;175(4):1262-7; discussion 1267. doi: 10.1016/S0022-5347(05)00644-0. J Urol. 2006. PMID: 16515975

6

Aggressive management of elderly patients with muscle-invasive bladder cancer.

Weizer AZ, Montie JE, Lee CT. Weizer AZ, et al. Among authors: lee ct. Nat Clin Pract Urol. 2006 Jul;3(7):346-7. doi: 10.1038/ncpuro0506. Nat Clin Pract Urol. 2006. PMID: 16835604 Review. No abstract available.

7

A case of T2 muscle-invasive bladder cancer treated with neoadjuvant chemotherapy.

Gilbert SM, Lee CT. Gilbert SM, et al. Among authors: lee ct. Nat Clin Pract Urol. 2006 Dec;3(12):675-9. doi: 10.1038/ncpuro0655. Nat Clin Pract Urol. 2006. PMID: 17149384 Review.

8

A rationale for developing benchmarks for the treatment of muscle-invasive bladder cancer.

Lee CT. Lee CT. Urol Oncol. 2007 Jan-Feb;25(1):57-65. doi: 10.1016/j.urolonc.2006.05.009. Urol Oncol. 2007. PMID: 17208141

9

Measuring health-related quality of life outcomes in bladder cancer patients using the Bladder Cancer Index (BCI).

Gilbert SM, Wood DP, Dunn RL, Weizer AZ, Lee CT, Montie JE, Wei JT. Gilbert SM, et al. Among authors: lee ct. Cancer. 2007 May 1;109(9):1756-62. doi: 10.1002/cncr.22556. Cancer. 2007. PMID: 17366596 Free article.

10

Performance status is a predictor of overall survival of elderly patients with muscle invasive bladder cancer.

Weizer AZ, Joshi D, Daignault S, Kinnaman M, Hussain M, Montie JE, Zhang Y, Lee CT. Weizer AZ, et al. Among authors: lee ct. J Urol. 2007 Apr;177(4):1287-93. doi: 10.1016/j.juro.2006.11.060. J Urol. 2007. PMID: 17382715

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,833 results

Search Page

Filters